JAGX vs. NBRV, AADI, IMRX, RMTI, CALC, CLNN, APLM, NXTC, BOLT, and BLRX
Should you be buying Jaguar Health stock or one of its competitors? The main competitors of Jaguar Health include Nabriva Therapeutics (NBRV), Aadi Bioscience (AADI), Immuneering (IMRX), Rockwell Medical (RMTI), CalciMedica (CALC), Clene (CLNN), Apollomics (APLM), NextCure (NXTC), Bolt Biotherapeutics (BOLT), and BioLineRx (BLRX). These companies are all part of the "pharmaceutical preparations" industry.
Nabriva Therapeutics (NASDAQ:NBRV) and Jaguar Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, community ranking, dividends, analyst recommendations, profitability, earnings and valuation.
Nabriva Therapeutics has a net margin of -148.11% compared to Nabriva Therapeutics' net margin of -423.11%. Jaguar Health's return on equity of -365.53% beat Nabriva Therapeutics' return on equity.
Nabriva Therapeutics has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500. Comparatively, Jaguar Health has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500.
In the previous week, Jaguar Health had 1 more articles in the media than Nabriva Therapeutics. MarketBeat recorded 2 mentions for Jaguar Health and 1 mentions for Nabriva Therapeutics. Jaguar Health's average media sentiment score of 0.00 equaled Nabriva Therapeutics'average media sentiment score.
Jaguar Health received 1442 more outperform votes than Nabriva Therapeutics when rated by MarketBeat users. Likewise, 89.21% of users gave Jaguar Health an outperform vote while only 58.48% of users gave Nabriva Therapeutics an outperform vote.
0.3% of Nabriva Therapeutics shares are held by institutional investors. Comparatively, 12.0% of Jaguar Health shares are held by institutional investors. 1.6% of Nabriva Therapeutics shares are held by company insiders. Comparatively, 0.2% of Jaguar Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Jaguar Health has lower revenue, but higher earnings than Nabriva Therapeutics.
Summary
Jaguar Health beats Nabriva Therapeutics on 6 of the 11 factors compared between the two stocks.
Get Jaguar Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jaguar Health Competitors List
Related Companies and Tools
